Treatment of Alzheimer's and Dementia With the Metabolism, Infections, Nutrition, Drug Elimination (MIND) Protocol
NCT02260167 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2020-05-08
Summary
Treating with measures that may improve metabolic functioning of neurons in an integrated protocol
Conditions
Interventions
- OTHER
-
A mix of natural treatments and medications
Sponsors & Collaborators
-
Practitioners Alliance Network
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-09-30
- Primary Completion
- 2017-12-31
- Completion
- 2017-12-31
Countries
- United States
Study Locations
More Related Trials
-
Clinical Efficacy of Ginkgo Biloba Extract in the Treatment of Alzheimer's Disease
NCT03090516 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Medium Chain Triglyceride Intervention for Patients With Alzheimer Disease
NCT02912936 ·Status: COMPLETED ·Phase: NA
-
A Clinical Trial of a Vitamin/Nutriceutical Formulation for Alzheimer's Disease
NCT01320527 ·Status: COMPLETED ·Phase: PHASE2
-
Treating Alzheimer's and Dementia With D-ribose
NCT02260141 ·Status: TERMINATED ·Phase: NA
-
Screening and Evaluation of Patients With Signs and Symptoms of Alzheimer's Disease
NCT00955422 ·Status: COMPLETED
-
Sirtuin-NAD Activator in Alzheimer's Disease
NCT05040321 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICE
NCT02860338 ·Status: COMPLETED
-
Metformin in Alzheimer's Dementia Prevention
NCT04098666 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Allogeneic Human Mesenchymal Stem Cells for Alzheimer's Disease
NCT02833792 ·Status: UNKNOWN ·Phase: PHASE2
-
Effects of ONO-2506PO in Patients With Alzheimer's Disease
NCT00083421 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial of AAV2-BDNF Gene Therapy in Early Alzheimer's Disease and Mild Cognitive Impairment
NCT05040217 ·Status: RECRUITING ·Phase: PHASE1
-
Acupuncture Treatment for Improving Alzheimer's Dementia
NCT04064021 ·Status: WITHDRAWN ·Phase: NA
-
Preventing Cognitive Decline With Alternative Therapies
NCT00010920 ·Status: COMPLETED ·Phase: PHASE3
-
ELND005 in Patients With Mild to Moderate Alzheimer's Disease
NCT00568776 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of PF-04360365 On ABETA In Patients With Alzheimer's Disease And Healthy Volunteers
NCT01005862 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Target Engagement of Centella Asiatica in Cognitive Impairment
NCT05591027 ·Status: RECRUITING ·Phase: PHASE1
-
Donepezil and Memantine in Moderate to Severe Alzheimer's Disease
NCT00866060 ·Status: UNKNOWN ·Phase: PHASE4
-
Nicotinic Acid for the Treatment of Alzheimer's Disease
NCT06582706 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Memory and Mental Health in Aging
NCT02988908 ·Status: COMPLETED ·Phase: PHASE4
-
APOE in the Predisposition to, Protection From, and Prevention of Alzheimer's Disease
NCT04994847 ·Status: ENROLLING_BY_INVITATION
-
Brain Amyloid- Retention During Wakefulness and Following Emergence From Sleep in Healthy People
NCT02669225 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Magnesium L-Threonate for the Enhancement of Learning and Memory in People With Dementia
NCT02210286 ·Status: COMPLETED ·Phase: NA
-
Effects of a NeuroAD System, for the Treatment of Alzheimer Disease
NCT02166827 ·Status: TERMINATED ·Phase: NA
-
CNS and Plasma Amyloid-Beta Kinetics in Alzheimer's Disease
NCT02021682 ·Status: COMPLETED
-
Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's
NCT00105547 ·Status: COMPLETED ·Phase: PHASE3